Boditech Med Statistics
Total Valuation
Boditech Med has a market cap or net worth of KRW 346.46 billion. The enterprise value is 308.61 billion.
Market Cap | 346.46B |
Enterprise Value | 308.61B |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
Boditech Med has 21.79 million shares outstanding. The number of shares has decreased by -0.13% in one year.
Current Share Class | n/a |
Shares Outstanding | 21.79M |
Shares Change (YoY) | -0.13% |
Shares Change (QoQ) | -0.64% |
Owned by Insiders (%) | 39.59% |
Owned by Institutions (%) | 1.84% |
Float | 13.04M |
Valuation Ratios
The trailing PE ratio is 12.80 and the forward PE ratio is 9.85.
PE Ratio | 12.80 |
Forward PE | 9.85 |
PS Ratio | 2.52 |
PB Ratio | 1.65 |
P/TBV Ratio | 1.68 |
P/FCF Ratio | 25.76 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.06, with an EV/FCF ratio of 22.94.
EV / Earnings | 11.32 |
EV / Sales | 2.23 |
EV / EBITDA | 9.06 |
EV / EBIT | 12.04 |
EV / FCF | 22.94 |
Financial Position
The company has a current ratio of 4.96, with a Debt / Equity ratio of 0.05.
Current Ratio | 4.96 |
Quick Ratio | 3.38 |
Debt / Equity | 0.05 |
Debt / EBITDA | 0.32 |
Debt / FCF | 0.82 |
Interest Coverage | 74.12 |
Financial Efficiency
Return on equity (ROE) is 12.95% and return on invested capital (ROIC) is 7.39%.
Return on Equity (ROE) | 12.95% |
Return on Assets (ROA) | 6.77% |
Return on Invested Capital (ROIC) | 7.39% |
Return on Capital Employed (ROCE) | 11.50% |
Revenue Per Employee | 281.39M |
Profits Per Employee | 55.52M |
Employee Count | 491 |
Asset Turnover | 0.57 |
Inventory Turnover | 1.62 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.86% in the last 52 weeks. The beta is 0.26, so Boditech Med's price volatility has been lower than the market average.
Beta (5Y) | 0.26 |
52-Week Price Change | +8.86% |
50-Day Moving Average | 15,827.40 |
200-Day Moving Average | 16,653.35 |
Relative Strength Index (RSI) | 52.16 |
Average Volume (20 Days) | 153,570 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Boditech Med had revenue of KRW 138.16 billion and earned 27.26 billion in profits. Earnings per share was 1,242.00.
Revenue | 138.16B |
Gross Profit | 81.29B |
Operating Income | 26.13B |
Pretax Income | 32.40B |
Net Income | 27.26B |
EBITDA | 34.57B |
EBIT | 26.13B |
Earnings Per Share (EPS) | 1,242.00 |
Balance Sheet
The company has 61.72 billion in cash and 11.09 billion in debt, giving a net cash position of 50.63 billion or 2,323.49 per share.
Cash & Cash Equivalents | 61.72B |
Total Debt | 11.09B |
Net Cash | 50.63B |
Net Cash Per Share | 2,323.49 |
Equity (Book Value) | 223.05B |
Book Value Per Share | 9,653.26 |
Working Capital | 108.44B |
Cash Flow
In the last 12 months, operating cash flow was 24.88 billion and capital expenditures -11.43 billion, giving a free cash flow of 13.45 billion.
Operating Cash Flow | 24.88B |
Capital Expenditures | -11.43B |
Free Cash Flow | 13.45B |
FCF Per Share | 617.34 |
Margins
Gross margin is 58.84%, with operating and profit margins of 18.91% and 19.73%.
Gross Margin | 58.84% |
Operating Margin | 18.91% |
Pretax Margin | 23.45% |
Profit Margin | 19.73% |
EBITDA Margin | 25.02% |
EBIT Margin | 18.91% |
FCF Margin | 9.74% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 0.97%.
Dividend Per Share | 150.00 |
Dividend Yield | 0.97% |
Dividend Growth (YoY) | -25.00% |
Years of Dividend Growth | 1 |
Payout Ratio | 16.12% |
Buyback Yield | 0.13% |
Shareholder Yield | 1.09% |
Earnings Yield | 7.87% |
FCF Yield | 3.88% |
Stock Splits
The last stock split was on April 5, 2017. It was a forward split with a ratio of 1.1.
Last Split Date | Apr 5, 2017 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Boditech Med has an Altman Z-Score of 9.36.
Altman Z-Score | 9.36 |
Piotroski F-Score | n/a |